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Abstract: Exertional dyspnoea is a leading symptom in patients with pulmonary arterial hypertension
(PAH). Patients suffering from PAH report poor quality of life, have skeletal muscle dysfunction and in
the absence of advanced medical therapy deteriorate progressively due to right heart failure which can lead
to death. For decades, patients with PAH were advised to avoid exercise in fear of exacerbated right heart
failure. Recently, it has been shown that a highly supervised rehabilitation programme in expert centres
leads to significant improvements in symptoms, quality of life, exercise capacity and may even enhance
haemodynamics in selected stable patients treated with advanced regimens of PAH-targeted drugs. As a
consequence of these promising results, pulmonary rehabilitation performed in an expert centre has been
included in recent guidelines. The underlying mechanisms are not completely understood, but positive
effects can be measured in different organ systems such as skeletal muscles, the cardiopulmonary system
and immune system (inflammation), and also on the psychological level. Thus, improvements in 6-minute
walking distance (6MWD), peak oxygen uptake (VO2 peak), muscle strength and muscle endurance, as
well as physical and mental quality of life scores (SF-36 questionnaire) have been shown. Different training
protocols have been used. Essential are qualified patient selection in expert centres, a low workload
endurance and dumbbell (weight lifting) training avoiding strenuous exercise and exhaustion, thorough
patient education and close supervision by experts especially during the first weeks. Adverse events may
occur (e.g., pre-/syncope, arrhythmia, respiratory infections). PAH patients tend to overestimate their
physical capacity, not perceiving their own limits properly, which makes education and expert advice
even more important as exercise training can also worsen the right heart failure. Therefore, a core issue
of the multidisciplinary rehabilitation is the close cooperation between the experienced rehabilitation
clinic offering a specialised programme for PAH patients and the PAH expert centre, which takes care
of the patient and is thoroughly involved in the training programme. Further multicentre international
randomised trials are needed to evaluate whether this specialised programme is feasible within different
healthcare systems and to assess long term effects and survival.
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Summary
Exertional dyspnoea is a leading symptom in patients with
pulmonary arterial hypertension (PAH). Patients suffering
from PAH report poor quality of life, have skeletal muscle
dysfunction and in the absence of advanced medical ther-
apy deteriorate progressively due to right heart failure
which can lead to death. For decades, patients with PAH
were advised to avoid exercise in fear of exacerbated right
heart failure. Recently, it has been shown that a highly su-
pervised rehabilitation programme in expert centres leads
to significant improvements in symptoms, quality of life,
exercise capacity and may even enhance haemodynam-
ics in selected stable patients treated with advanced regi-
mens of PAH-targeted drugs. As a consequence of these
promising results, pulmonary rehabilitation performed in
an expert centre has been included in recent guidelines.
The underlying mechanisms are not completely under-
stood, but positive effects can be measured in different
organ systems such as skeletal muscles, the cardiopul-
monary system and immune system (inflammation), and
also on the psychological level. Thus, improvements in
6-minute walking distance (6MWD), peak oxygen uptake
(VO2 peak), muscle strength and muscle endurance, as
well as physical and mental quality of life scores (SF-36
questionnaire) have been shown. Different training proto-
cols have been used. Essential are qualified patient se-
lection in expert centres, a low workload endurance and
dumbbell (weight lifting) training avoiding strenuous exer-
cise and exhaustion, thorough patient education and close
supervision by experts especially during the first weeks.
Adverse events may occur (e.g., pre-/syncope, arrhyth-
mia, respiratory infections). PAH patients tend to overesti-
mate their physical capacity, not perceiving their own limits
properly, which makes education and expert advice even
more important as exercise training can also worsen the
right heart failure. Therefore, a core issue of the multidis-
ciplinary rehabilitation is the close cooperation between
the experienced rehabilitation clinic offering a specialised
programme for PAH patients and the PAH expert centre,
which takes care of the patient and is thoroughly involved
in the training programme. Further multicentre internation-
al randomised trials are needed to evaluate whether this
specialised programme is feasible within different health-
care systems and to assess long term effects and survival.
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Introduction
Pulmonary arterial hypertension (PAH) is a disease of the
pulmonary vasculature leading to an increase in pulmonary
vascular pressure (mean arterial pulmonary pressure
≥25 mm Hg) causing exertional dyspnoea and progressive
right heart failure. Exertional dyspnoea is the hallmark
symptom of the disease. In early stages the exertional dys-
pnoea is often not attributed to PAH, which leads to a delay
in the diagnosis in many cases. When the vascular remod-
elling is more advanced and the pulmonary artery pres-
sure rises, further symptoms of right heart failure devel-
op such as presyncope or syncope and clinical signs of
right-sided heart failure [1]. For many years, PAH patients
were advised not to practice strenuous activities and sports.
Exercise was feared because of a possible risk of sudden
cardiac death, increased pulmonary remodelling resulting
from higher shear stress during activity, and worsening of
right heart failure [2]. Because of a lack of efficacy data,
in the guidelines of 2009 rehabilitation was considered
only in special circumstances, such as in deconditioned
PAH patients, and only in a highly supervised setting with
avoidance of strenuous and excessive physical activity [3].
Since then, more studies have been performed that pro-
vided clearer evidence of improvements of symptoms and
exercise performance with reassuring data on safety [4,
5]. However, it must be emphasised that the patients in
these studies were all in a stable condition, on advanced
drug therapy, under close supervision in PAH expert cen-
tres and the training was specially designed for PAH pa-
tients. In the new updated guidelines of 2015, this highly
specialised PAH rehabilitation is recommended for sta-
ble patients on optimised pharmacological treatment and
with the notion that supervised rehabilitation should be
implemented by centres experienced in both PAH patient
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recommendation, evidence level B). Optimised pharma-
cological treatment is defined as single or combination
therapy with PAH-targeted drug therapy such as calcium-
channel blockers, endothelin receptor antagonists, phos-
phodiesterase type 5 inhibitors, guanylate cyclase stim-
ulators and prostacyclin analogues. The guidelines also
clearly suggest that such an expert centre should consist of
a multidisciplinary team including cardiology and respira-
tory medicine physicians, specialised nurses and radiolo-
gists. Furthermore, a direct link to adult congenital heart
disease units, pulmonary endarterectomy surgeons and a
lung transplantation programme is proposed. Regarding
size and daily routine of the expert centre, it is required that
at least 50 patients with PAH or chronic thromboembolic
pulmonary hypertension (CTEPH) should be followed up,
and the expert centre should have two new referrals per
months [1].
Rehabilitation, reactivation and physical activ-
ity
In ancient times, walking and physical activity were al-
ready recognised as one of the most effective medicines.
Hippocrates, the famous Greek physician and outstanding
figure in the history of medicine, was reputed to have said
“walking is man’s best medicine”. Chronic cardiorespira-
tory disorders with disabling symptoms lead to physical
inactivity, skeletal muscle dysfunction and compromised
quality of life. In addition to optimal medical therapy, it
is thus important to improve exercise capacity and phys-
ical activity in these patients [6, 7]. Rehabilitation is a
very potent, important and evidence-based intervention to
achieve these essential goals. It is a comprehensive inter-
vention that not only consists of exercise training, but al-
so includes a multidisciplinary team, which provides infor-
mation, counselling and therapeutic interventions leading
to an improved physical and emotional status, and supports
behavioural changes to a more health promoting lifestyle
in daily life [6, 7]. Especially for PAH patients, it is essen-
tial to recognise their physical limits and avoid overexer-
cise in order to prevent dangerous side effects of exercise.
It is known that healthy persons and chronically ill patients
with higher physical activity in their daily life have a better
long-term survival than less active controls [8–11]. Epi-
demiological studies also showed a reduced incidence of
cardiovascular disease, cancer and diabetes with a more
active lifestyle [12, 13]. In patients with chronic obstruc-
tive pulmonary disease (COPD), higher physical activity
is linked to lower hospital admissions and reduced mor-
tality [9]. Therefore, it is a great issue in rehabilitation to
get disabled chronic respiratory patients back on track by
improving their exercise capacity and promoting an active
lifestyle that leads to a sustained behavioural change, im-
proved self-management and increased self-efficacy. This
knowledge and practice in general cardiopulmonary reha-
bilitation cannot be extrapolated to PAH patients without
modification, because this patient group is different in
many ways. Patients are often unaware of their own phys-
ical limits and tend to overexercise, which could worsen
right heart failure.
Pathogenetic mechanisms
The exact pathophysiological mechanisms by which ex-
ercise leads to beneficial or harmful effects are not yet
fully understood. In mice, exercise training prevented hy-
poxia-induced pulmonary vascular remodelling, and im-
proved exercise capacity and pulmonary haemodynamics
[14]. The effect on physical capacity was greatest in mice
who received drug treatment (sildenafil) in combination
with exercise training. Prevention of right ventricular hy-
pertrophy was not achieved, though. In other rat and mice
experiments, reduction in pulmonary artery diameter and
right ventricular end-diastolic pressure, improved capillary
density and attenuation of acute vasoconstriction in re-
sponse to hypoxia were demonstrated [15, 16]. Inflamma-
tion is involved in the development of PAH, and exercise
training has been shown to reduce inflammation in patients
with chronic heart failure and PAH [17–19].
Skeletal muscle is a key component of exercise perfor-
mance. Nowadays, skeletal muscle has been identified not
only as an organ translating energy into force but also as a
secretory organ. It is the largest organ in the body and ex-
erts paracrine, autocrine and endocrine effects by releasing
different mediators [20]. These various mediators, some of
them not known in detail yet, lead to multiple effects such
as better adipose tissue oxidation, improvement in insulin
sensitivity, better osteogenesis, anti-inflammatory effects,
higher antitumoural defence, improved pancreas function
and probably even favourable neurocognitive effects [21,
22]. The skeletal muscle in PAH patients is altered and
shows lower capillarisation, fewer type IIa fibres, less ox-
idative enzyme activity, reduced contractility and muscle
atrophy [23–25]. Exercise training can significantly im-
prove these alterations in muscle tissue. The mechanisms
and effects of exercise training on PAH are summarised in
figure 1.
Rehabilitation programme in pulmonary arte-
rial hypertension
Most of the evidence, understanding and experience in pul-
monary rehabilitation results from patients with COPD, as
this is the largest group of patients referred to pulmonary
rehabilitation programmes. The rehabilitation programme
for patients with PAH should be clearly distinguished from
these common programmes, and specifically tailored for
this rare patient group with its special needs. Besides a dis-
tinct patient educational programme, there are important
issues to consider in the exercise training protocols in or-
Figure 1: Effects of exercise training in PAH patients. Adapted
from [26].
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der to guarantee the highest level of safety possible in this
sensitive disease group. Other interventions such as psy-
chological, social and nutritional support are widely shared
over chronic diseases, but have to be individualised based
on a careful initial assessment.
Over the last 10 years, several studies in PAH patients in-
vestigated different training protocols. A worldwide con-
sensus on how to train PAH patients does not exist. The
need for clarification through further studies is under-
scored by the foundation of a specific task force on reha-
bilitation endorsed by the European Respiratory Society,
which will hopefully lead to high quality research in this
field. PAH training programmes consist of aerobic and re-
sistance training, which may vary among centres. Most
published studies were conducted in the PAH centre in
Heidelberg, Germany [2, 26]. They established a training
programme, which started as a 3-week inpatient training
followed by a home-based training after profound instruc-
tion and supervision of the respective expert centre. Before
the rehabilitation and right after the 3-week in-hospital
programme, patients are evaluated in the PAH centre to as-
sess stable status under optimal PAH medical therapy, to
assess the initial exercise training intensity, and to counsel
patients and trainers. During these visits at the expert cen-
tre, every PAH patient is assessed by echocardiography at
rest and during exercise and by ergospirometry to evalu-
ate peak oxygen uptake (peak VO2), heart rate response to
exercise, contractile reserve and further safety parameters.
During the following 3 weeks of in-hospital rehabilitation,
the physicians for rehabilitation stay in daily contact with
the PAH experts. The rehabilitation programme consists
of low-intensity interval bicycle ergometer training (aver-
age workloads only 5 to 40 watts) for 10 to 25 minutes
in a supervised and monitored setting, low-dose dumbbell
training of single muscle groups with low weights, and
respiratory therapy, in which patients are taught percep-
tion of breathing and methods to relieve dyspnoea (deep
breathing exercises and positions facilitating respiration).
Patients are also educated in perceiving their physical lim-
its and optimal pacing in guided mental walking training
under supervision of specially trained physiotherapists [4].
Other centres have also used treadmill walking for 30 to
45 minutes under similarly intensive supervision [27, 28].
In summary, the majority of published studies used aerobic
exercise training with low workload (intensity titrated be-
tween 40 to 80% of peak exercise capacity). Participants in
these studies were clinically stable and treated with opti-
mised PAH drug therapy without signs of overt right heart
failure. Training was performed under close supervision by
PAH experts [26, 28]. The different components of the re-
habilitation programme are listed in table 1.
Evidence and effects of rehabilitation in pul-
monary vascular disease
The body of clinical data has grown over the last years, but
randomised controlled studies are still scarce. Most stud-
ies are performed in an in-hospital setting for safety rea-
sons and, as underscored above, all these studies have been
performed in a highly specialised setting under close ex-
pert supervision. To increase knowledge in this field, larger
multicentre international studies including patients in var-
ious healthcare systems are highly desired, and hopefully
the task force on PAH rehabilitation of the European Res-
piratory Society will advance this field. In a review article
and a systematic review, the pooled number of patients in-
cluded in studies were approximately 470 [26, 28]. Bene-
ficial effects of exercise training are improvement in exer-
cise capacity measured by the 6-minute walking distance
(6MWD), VO2 peak and higher oxygen uptake at anaero-
bic threshold (VO2 at anaerobic threshold), increased car-
diac output [29], and improvement in muscle strength and
muscle endurance. Also, patient-reported outcomes such
as the physical and mental quality of life scores measured
with the SF-36 questionnaire improved significantly, espe-
cially in the domains of physical functioning, role physical,
general health perception, vitality, social functioning, role
emotional and mental health [4].
The improvement in the 6MWD was replicated in several
studies. In a systematic review of 16 studies with a total
of 469 participants, the weighted mean improvement was
53.3 m, exceeding the minimum clinically important dif-
ference of 33 m by far [28, 30]. This significant improve-
ment of exercise capacity in patients on advanced disease-
targeted drug treatment highlights the value of this struc-
tured rehabilitation. The effects were robust in different
forms of pulmonary vascular diseases, such as idiopathic
PAH, associated PAH, CTEPH and pulmonary hyperten-
sion due to respiratory or left heart diseases [5]. Self-re-
ported compliance rates with the regular physical exercise
training after the inpatient rehabilitation were high (vary
from 92 to 61%) and patients with higher compliance had
a better increase in their physical capacity. The follow-up
period ranged from 15 weeks up to 5 years. If effective
self-management behaviour can be achieved, the effects
are sustainable and a very favourable long-term survival
has been observed [2, 31–33].
As for every intervention, there are nonresponders to ex-
ercise training, and future research may clarify which pa-
tients may not respond or even deteriorate. Some patients
experience adverse effects during the rehabilitation pro-
gramme (e.g., syncope, worsening of right heart failure or
respiratory tract infection). Exercise training may also not
be suitable for every patient with pulmonary vascular dis-
Table 1: Different components of the rehabilitation programme in pa-
tients with pulmonary arterial hypertension (PAH).
Intervention Comment
Expert education and su-
pervision
It is a prerequisite for training in PAH to
perform this in collaboration with a PAH
expert centre with programmes specifi-
cally tailored to groups of PAH patients.
Aerobic exercise training Low workload, e.g., aerobic bicycle train-
ing (40–80% of peak exercise capacity).
Monitoring oxygen saturation (>90%)
and heart rate (<120/min). For 10 to 25
minutes. Frequency: daily.
Resistance training Dumbbell with low weights for 30 min-
utes. Frequency: 5 times/week.
Mental walking training Guidance in exploring individual physical
limits and pacing. Frequency: several
times/week.
Respiratory therapy For 30 minutes. Frequency: 5 times/
week.
Psychological support If needed.
Nutritional support If needed.




Review article: Medical guidelines Swiss Med Wkly. 2017;147:w14462
Swiss Medical Weekly · PDF of the online version · www.smw.ch
Published under the copyright license “Attribution – Non-Commercial – No Derivatives 4.0”.
No commercial reuse without permission. See http://emh.ch/en/services/permissions.html.
Page 3 of 5
ease, or may need to be specifically tailored to subgroups,
such as patients with comorbidities (orthopaedic problems,
mental disorders such as depression and anxiety) or for
very young patients with an early diagnosis who are al-
ready relatively fit, as indicated by near-normal 6MWD
(>550 m) [26].
Adverse events and practical aspects
In published studies, adverse events in highly specialist
centres under expert supervision were relatively rare. In the
largest study, a total of 13.6% of participants suffered ad-
verse events. Nearly half of these patients developed acute
respiratory infections that had to be treated with antibiotics
and needed intermittent discontinuation of the training pro-
gramme [5]. Other events were presyncope, syncope, ar-
rhythmias and haemoptysis. In some studies dizziness, pal-
pitation, hypotension and oxygen desaturation were also
reported. These adverse events occurred in less than 5% of
patients [28]. PAH participants are often not aware of their
physical limitations, tend to exaggerate physical training
and need to be slowed down. They also have to be guided
and taught to recognise their own limits. In some centres,
including ours, a mental gait training, in which patients
learn to perceive their limit and learn to pace themselves
adequately, is successfully established to address this need.
To reach this goal, a good relationship between the patient
and the therapist is needed, which can be built during indi-
vidual sessions and therapy in small groups.
To minimise adverse events, some safety precautions have
to be implemented when starting any PAH patient on a
physical training programme. As repeatedly stated, it is a
prerequisite that every PAH patient is in a clinically sta-
ble condition on optimised PAH targeted medication for at
least 2 months under expert supervision [26]. Additionally,
it is strongly recommended to start the rehabilitation pro-
gramme in an inpatient setting, where both close supervi-
sion during training and observation after the training is
possible, especially for patients in functional class III–IV,
as adverse events can occur hours after training. It is cru-
cial that training is initiated with very low workloads (be-
tween 40–-80% of peak exercise capacity). Oxygen sat-
uration and heart frequency should be monitored closely
(saturation >85%, peak heart rate <120 per minute). The
dumbbell training has to be performed with low weights
involving single muscle groups only. The main recommen-
dations are summarised in table 2.
Conclusions
Pulmonary rehabilitation in PAH patients is a recommend-
ed therapy in addition to optimal medical therapy with
PAH targeted drugs, if performed in a highly experienced
team under expert supervision. Supervised rehabilitation
should be implemented by centres experienced in both
PAH patient care and rehabilitation of compromised pa-
tients, and be especially tailored to groups of PAH patients.
It leads to significant improvements in symptoms, exercise
capacity and quality of life. The pathomechanisms are not
fully understood yet. Patients starting exercise training
have to be in stable condition on optimised medical thera-
py. In close collaboration with and supervision by a PAH
expert centre, specially tailored exercise training for PAH
patients is relatively safe. It is essential to use a low work-
load exercise protocol with careful individual adjustments,
to avoid overloading of patients. The core piece of the pul-
monary rehabilitation programme is to teach PAH patients
to accept the disease, not to overdo themselves and to con-
tinue with low-dose exercise training for at least 15 min-
utes per day at least 5 days per week. Further randomised
controlled studies are needed to assess whether this spe-
cialised PAH training programme can be implemented in
different healthcare systems and to evaluate the effect of
exercise training on follow-up and survival.
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